TARS - Tarsus Pharmaceuticals' President & CEO disposes 8000 shares
2023-09-25 11:07:51 ET
More on Tarsus Pharmaceuticals
- Seeking Alpha’s Quant Rating on Tarsus Pharmaceuticals
- Historical earnings data for Tarsus Pharmaceuticals
- Financial information for Tarsus Pharmaceuticals
- Tarsus granted FDA nod for lead asset
- Tarsus started at overweight at William Blair on eyelid inflammation asset
For further details see:
Tarsus Pharmaceuticals' President & CEO disposes 8,000 shares